SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-095672
Filing Date
2021-07-26
Accepted
2021-07-26 10:42:26
Documents
4
Period of Report
2021-08-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm212631-9_def14a.htm DEF 14A 293859
2 GRAPHIC lg_neurobopharma-4c.jpg GRAPHIC 45889
3 GRAPHIC tm212631d9-pc_neuropg14c.jpg GRAPHIC 1003624
4 GRAPHIC tm212631d9-pc_neuropg24c.jpg GRAPHIC 318444
  Complete submission text file 0001104659-21-095672.txt   2179479
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37809 | Film No.: 211112898
SIC: 2834 Pharmaceutical Preparations